PROKIDNEY
ProKidney offers treatment of chronic kidney disease (CKD) through innovations in cellular therapy. ProKidney’s lead product candidate, REACT™ (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT™ has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting its ongoing Phase 3 clinical program.
PROKIDNEY
Industry:
Health Care Therapeutics
Founded:
2015-01-01
Address:
Salem, Oregon, United States
Country:
United States
Website Url:
http://www.prokidney.com
Total Employee:
1+
Status:
Active
Total Funding:
205 M USD
Similar Organizations
KfH
KfH offers comprehensive treatment for chronic kidney disease patients.
Renal Research Institute
The Renal Research Institute provides treatment for chronic kidney disease (CKD).
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Suvretta Capital Management
Suvretta Capital Management investment in Post-IPO Equity - Prokidney
Social Capital
Social Capital investment in Post-IPO Equity - Prokidney
Key Employee Changes
Official Site Inspections
http://www.prokidney.com Semrush global rank: 3.73 M Semrush visits lastest month: 3.67 K
- Host name: 162.138.209.35.bc.googleusercontent.com
- IP address: 35.209.138.162
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
